Clinical trial · Observational
Micro-RNA Expression Profiles in Localised Prostate Cancer
NCT03338712CI-TRIAL-00072189withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Principal Investigators no longer in business
Summary
Brief summary (as posted)
Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Radical Prostatectomy | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Recurrence free survival
- timeFrame
- Up to 120 months. From date of inclusion until date of death from any cause
- description
- The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.
Secondary outcomes (1)
- measure
- Cancer specific survival
- timeFrame
- Up to 120 months. From date of inclusion until date of death from any cause
- description
- Cancer specific survival
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 35 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * 35 Years to 80 Years * Male * Patients with clinically localised high risk prostate cancer Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.